Summary
The Cigna Group (CI) has announced a significant debt issuance, filing an 8-K report on February 7, 2024, detailing the sale of $4.5 billion in aggregate principal amount of Senior Notes across various maturities. These notes include 5.000% Senior Notes due 2029 ($1 billion), 5.125% Senior Notes due 2031 ($750 million), 5.250% Senior Notes due 2034 ($1.25 billion), and 5.600% Senior Notes due 2054 ($1.5 billion). This debt issuance is strategically aimed at financing its previously announced tender offers for outstanding notes with maturities between 2024 and 2030, up to an aggregate principal amount of $2.25 billion. Any remaining proceeds will be allocated towards the repayment of its 0.613% Senior Notes due 2024 at maturity and for general corporate purposes, which could include further debt repayment or share repurchases. This move indicates a proactive approach to managing its debt profile and capital structure.
Key Highlights
- 1Cigna Group issued $4.5 billion in Senior Notes across four tranches with varying interest rates and maturity dates (2029, 2031, 2034, 2054).
- 2The issuance includes notes with coupon rates ranging from 5.000% to 5.600%.
- 3Proceeds are earmarked to fund tender offers for up to $2.25 billion of existing outstanding notes.
- 4Remaining funds will be used to repay 0.613% Senior Notes due 2024 at maturity.
- 5General corporate purposes, including potential debt repayment and share repurchases, are also covered by the remaining proceeds.
- 6The debt issuance was conducted under the company's existing shelf registration statement on Form S-3ASR.
- 7The Underwriting Agreement includes standard provisions for representations, warranties, conditions, indemnification, and termination.